Gap finder

Search review questions

Each row is one question a systematic review asked: who, what, compared with what, and which outcome, with the effect it found and how certain that is. Words match anywhere in the field.

Population

Intervention or exposure

Comparison

Outcome

Any field or review title

Field or topic

Source

Review versions

434 questions in 75 reviews · Metabolic and Endocrine Disorders

current versions

No studies 434 · 100%Ungraded 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Question	Effect	Evidence	Status / GRADE
Intervention NR Socioeconomic effects · children (aged 6 to 11 years) being overweight or obese Diet, physical activity and behavioural interventions for the treatment of overweight or obese children from… (2017) · Cochrane	no estimate extracted	NR	No studies
Intervention NR All‐cause mortality · adolescents (aged 12‐17 years) being overweight or obese Diet, physical activity and behavioural interventions for the treatment of overweight or obese adolescents… (2017) · Cochrane	no estimate extracted	NR	No studies
Intervention NR Morbidity · adolescents (aged 12‐17 years) being overweight or obese Diet, physical activity and behavioural interventions for the treatment of overweight or obese adolescents… (2017) · Cochrane	no estimate extracted	NR	No studies
Intervention NR Socioeconomic effects · adolescents (aged 12‐17 years) being overweight or obese Diet, physical activity and behavioural interventions for the treatment of overweight or obese adolescents… (2017) · Cochrane	no estimate extracted	NR	No studies
Intervention NR All‐cause mortality Insulin monotherapy compared with the addition of oral glucose‐lowering agents to insulin for people with… (2016) · Cochrane	no estimate extracted	NR	No studies
Intervention NR Diabetes‐related morbidity Insulin monotherapy compared with the addition of oral glucose‐lowering agents to insulin for people with… (2016) · Cochrane	no estimate extracted	NR	No studies
Intervention NR Health‐related quality of life Insulin monotherapy compared with the addition of oral glucose‐lowering agents to insulin for people with… (2016) · Cochrane	no estimate extracted	NR	No studies
Intervention NR Patient satisfaction Insulin monotherapy compared with the addition of oral glucose‐lowering agents to insulin for people with… (2016) · Cochrane	no estimate extracted	NR	No studies
Intervention NR All‐cause mortality Insulin monotherapy compared with the addition of oral glucose‐lowering agents to insulin for people with… (2016) · Cochrane	no estimate extracted	NR	No studies
Intervention NR Diabetes‐related mortality Insulin monotherapy compared with the addition of oral glucose‐lowering agents to insulin for people with… (2016) · Cochrane	no estimate extracted	NR	No studies
Intervention NR Diabetes‐related morbidity Insulin monotherapy compared with the addition of oral glucose‐lowering agents to insulin for people with… (2016) · Cochrane	no estimate extracted	NR	No studies
Intervention NR Health‐related quality of life Insulin monotherapy compared with the addition of oral glucose‐lowering agents to insulin for people with… (2016) · Cochrane	no estimate extracted	NR	No studies
Intervention NR Patient satisfaction Insulin monotherapy compared with the addition of oral glucose‐lowering agents to insulin for people with… (2016) · Cochrane	no estimate extracted	NR	No studies
Intervention NR Diabetes‐related mortality Insulin monotherapy compared with the addition of oral glucose‐lowering agents to insulin for people with… (2016) · Cochrane	no estimate extracted	NR	No studies
Intervention NR All‐cause mortality Insulin monotherapy compared with the addition of oral glucose‐lowering agents to insulin for people with… (2016) · Cochrane	no estimate extracted	NR	No studies
Intervention NR Diabetes‐related mortality Insulin monotherapy compared with the addition of oral glucose‐lowering agents to insulin for people with… (2016) · Cochrane	no estimate extracted	NR	No studies
Intervention NR Diabetes‐related morbidity Insulin monotherapy compared with the addition of oral glucose‐lowering agents to insulin for people with… (2016) · Cochrane	no estimate extracted	NR	No studies
Intervention NR Health‐related quality of life Insulin monotherapy compared with the addition of oral glucose‐lowering agents to insulin for people with… (2016) · Cochrane	no estimate extracted	NR	No studies
Intervention NR Patient satisfaction Insulin monotherapy compared with the addition of oral glucose‐lowering agents to insulin for people with… (2016) · Cochrane	no estimate extracted	NR	No studies
Intervention NR All‐cause mortality Insulin monotherapy compared with the addition of oral glucose‐lowering agents to insulin for people with… (2016) · Cochrane	no estimate extracted	NR	No studies
Intervention NR Diabetes‐related morbidity Insulin monotherapy compared with the addition of oral glucose‐lowering agents to insulin for people with… (2016) · Cochrane	no estimate extracted	NR	No studies
Intervention NR Diabetes‐related mortality Insulin monotherapy compared with the addition of oral glucose‐lowering agents to insulin for people with… (2016) · Cochrane	no estimate extracted	NR	No studies
Intervention NR Diabetes‐related morbidity Insulin monotherapy compared with the addition of oral glucose‐lowering agents to insulin for people with… (2016) · Cochrane	no estimate extracted	NR	No studies
Intervention NR Health‐related quality of life Insulin monotherapy compared with the addition of oral glucose‐lowering agents to insulin for people with… (2016) · Cochrane	no estimate extracted	NR	No studies
Intervention NR Patient satisfaction Insulin monotherapy compared with the addition of oral glucose‐lowering agents to insulin for people with… (2016) · Cochrane	no estimate extracted	NR	No studies
Intervention NR Health‐related quality of life Insulin monotherapy compared with the addition of oral glucose‐lowering agents to insulin for people with… (2016) · Cochrane	no estimate extracted	NR	No studies
Intervention NR Patient satisfaction Insulin monotherapy compared with the addition of oral glucose‐lowering agents to insulin for people with… (2016) · Cochrane	no estimate extracted	NR	No studies
Intervention NR All‐cause mortality Insulin monotherapy compared with the addition of oral glucose‐lowering agents to insulin for people with… (2016) · Cochrane	no estimate extracted	NR	No studies
Intervention NR Diabetes‐related mortality Insulin monotherapy compared with the addition of oral glucose‐lowering agents to insulin for people with… (2016) · Cochrane	no estimate extracted	NR	No studies
Subcutaneous insulin aspart vs intravenous regular insulin Morbidity Subcutaneous rapid‐acting insulin analogues for diabetic ketoacidosis (2016) · Cochrane	no estimate extracted	NR	No studies
Subcutaneous insulin aspart vs intravenous regular insulin Adverse events other than hypoglycaemic episodes Subcutaneous rapid‐acting insulin analogues for diabetic ketoacidosis (2016) · Cochrane	no estimate extracted	NR	No studies
Subcutaneous insulin aspart vs intravenous regular insulin Patient satisfaction Subcutaneous rapid‐acting insulin analogues for diabetic ketoacidosis (2016) · Cochrane	no estimate extracted	NR	No studies
Subcutaneous insulin lispro vs intravenous regular insulin Adverse events other than hypoglycaemic episodes Subcutaneous rapid‐acting insulin analogues for diabetic ketoacidosis (2016) · Cochrane	no estimate extracted	NR	No studies
Subcutaneous insulin lispro vs intravenous regular insulin Patient satisfaction Subcutaneous rapid‐acting insulin analogues for diabetic ketoacidosis (2016) · Cochrane	no estimate extracted	NR	No studies
Intervention NR Diabetes‐related complications · adults with type 2 diabetes and severe mental illness Self management interventions for type 2 diabetes in adult people with severe mental illness (2016) · Cochrane	no estimate extracted	NR	No studies
Intervention NR All‐cause mortality · adults with type 2 diabetes and severe mental illness Self management interventions for type 2 diabetes in adult people with severe mental illness (2016) · Cochrane	no estimate extracted	NR	No studies
Intervention NR Adverse events · adults with type 2 diabetes and severe mental illness Self management interventions for type 2 diabetes in adult people with severe mental illness (2016) · Cochrane	no estimate extracted	NR	No studies
Intervention NR Health‐related quality of life · adults with type 2 diabetes and severe mental illness Self management interventions for type 2 diabetes in adult people with severe mental illness (2016) · Cochrane	no estimate extracted	NR	No studies
Intervention NR Socioeconomic effects · adults with type 2 diabetes and severe mental illness Self management interventions for type 2 diabetes in adult people with severe mental illness (2016) · Cochrane	no estimate extracted	NR	No studies
Intervention NR Health‐related quality of life and self esteem · preschool children (aged 0 to 6 years) with overweight or obesity Diet, physical activity, and behavioural interventions for the treatment of overweight or obesity in… (2016) · Cochrane	no estimate extracted	NR	No studies
Intervention NR All‐cause mortality · preschool children (aged 0 to 6 years) with overweight or obesity Diet, physical activity, and behavioural interventions for the treatment of overweight or obesity in… (2016) · Cochrane	no estimate extracted	NR	No studies
Intervention NR Morbidity · preschool children (aged 0 to 6 years) with overweight or obesity Diet, physical activity, and behavioural interventions for the treatment of overweight or obesity in… (2016) · Cochrane	no estimate extracted	NR	No studies
Intervention NR Parent‐child relationship or assessment of parenting · preschool children (aged 0 to 6 years) with overweight or obesity Diet, physical activity, and behavioural interventions for the treatment of overweight or obesity in… (2016) · Cochrane	no estimate extracted	NR	No studies
Intervention NR Socioeconomic effects · preschool children (aged 0 to 6 years) with overweight or obesity Diet, physical activity, and behavioural interventions for the treatment of overweight or obesity in… (2016) · Cochrane	no estimate extracted	NR	No studies
Intervention NR All‐cause mortality · preschool children (aged 0 to 6 years) with overweight or obesity Diet, physical activity, and behavioural interventions for the treatment of overweight or obesity in… (2016) · Cochrane	no estimate extracted	NR	No studies
Intervention NR Morbidity · preschool children (aged 0 to 6 years) with overweight or obesity Diet, physical activity, and behavioural interventions for the treatment of overweight or obesity in… (2016) · Cochrane	no estimate extracted	NR	No studies
Intervention NR Socioeconomic effects · preschool children (aged 0 to 6 years) with overweight or obesity Diet, physical activity, and behavioural interventions for the treatment of overweight or obesity in… (2016) · Cochrane	no estimate extracted	NR	No studies
Intervention NR Adverse events · preschool children (aged 0 to 6 years) with overweight or obesity Diet, physical activity, and behavioural interventions for the treatment of overweight or obesity in… (2016) · Cochrane	no estimate extracted	NR	No studies
Intervention NR Health‐related quality of life · people at risk for the development of type 2 diabetes mellitus Insulin secretagogues for prevention or delay of type 2 diabetes mellitus and its associated complications… (2016) · Cochrane	no estimate extracted	NR	No studies
Intervention NR Serious adverse events · people at risk for the development of type 2 diabetes mellitus Insulin secretagogues for prevention or delay of type 2 diabetes mellitus and its associated complications… (2016) · Cochrane	no estimate extracted	NR	No studies